Clinical Trial Update: Safety Assessment of Atomoxetine With MA IV Administration [Phase 1]

View source ↗

Summary

Phase 1 safety assessment of atomoxetine given with intravenous methamphetamine in individuals with methamphetamine abuse or dependence; the study was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Abuse
• Methamphetamine Dependence

Drugs mentioned

• Atomoxetine (Atomoxetine)
• Methamphetamine (methamphetamine)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Methamphetamine Abuse, Methamphetamine Dependence | Phase 1 | Status: TERMINATED | Results posted: 2013-07-31